|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent Neogen insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why Neogen insider buys are important for investors to follow.
Date | Insider | Price | Amount |
4-17-2024 Insider Buy |
Douglas Edward Jones Chief Operating Officer |
$12.36
CAGR »
|
$123,590.00 10,000 shares |
4-10-2024 Insider Buy |
David H. Naemura CFO |
$12.51
CAGR »
|
$156,321.25 12,500 shares |
4-11-2024 Insider Buy |
James C. Borel Director |
$13.06
CAGR »
|
$97,986.00 7,500 shares |
4-10-2024 Insider Buy |
John Edward Adent CEO |
$12.36
CAGR »
|
$284,190.30 23,000 shares |
11-3-2023 Insider Buy |
William T. Boehm Director |
$16.05
CAGR »
|
$32,110.00 2,000 shares |
10-25-2023 Insider Buy |
Douglas Edward Jones Chief Operating Officer |
$15.17
CAGR »
|
$151,727.00 10,000 shares |
10-12-2023 Insider Buy |
James P. Tobin Director |
$15.19
CAGR »
|
$45,567.00 3,000 shares |
1-13-2023 Insider Buy |
Douglas Edward Jones Chief Operating Officer |
$17.91
CAGR »
|
$44,775.00 2,500 shares |
10-11-2022 Insider Buy |
Steven J. Quinlan VP & CFO |
$11.63
CAGR »
|
$58,150.00 5,000 shares |
10-3-2022 Insider Buy |
William T. Boehm Director |
$13.88
CAGR »
|
$27,770.00 2,000 shares |
9-28-2022 Insider Buy |
John Edward Adent President & CEO |
$14.37
CAGR »
|
$316,140.00 22,000 shares |
9-28-2022 Insider Buy |
Douglas Edward Jones Chief Operating Officer |
$14.31
CAGR »
|
$100,170.00 7,000 shares |
8-16-2022 Insider Buy |
Darci L. Vetter Director |
$21.83
CAGR »
|
$24,013.00 1,100 shares |
7-27-2022 Insider Buy |
James C. Borel Director |
$22.70
CAGR »
|
$147,528.55 6,500 shares |
8-2-2022 Insider Buy |
Ronald D. Green Director |
$22.50
CAGR »
|
$33,750.00 1,500 shares |
7-29-2022 Insider Buy |
John Edward Adent President & CEO |
$23.07
CAGR »
|
$403,725.00 17,500 shares |
7-27-2022 Insider Buy |
James P. Tobin Director |
$22.98
CAGR »
|
$45,960.00 2,000 shares |
1-25-2022 Insider Buy |
Douglas Edward Jones Chief Commercial Officer |
$35.78
CAGR »
|
$50,092.00 1,400 shares |
9-23-2021 Insider Buy |
James P. Tobin Director |
$42.92
CAGR »
|
$42,920.00 1,000 shares |
3-26-2020 Insider Buy |
James P. Tobin Director |
$60.62
CAGR »
|
$44,495.08 734 shares |
1-8-2020 Insider Buy |
John Edward Adent President & CEO |
$65.40
CAGR »
|
$99,211.80 1,517 shares |
3-25-2020 Insider Buy |
John Edward Adent President & CEO |
$58.24
CAGR »
|
$101,920.00 1,750 shares |
9-26-2018 Insider Buy |
John Edward Adent President & CEO |
$73.58
CAGR »
|
$316,394.00 4,300 shares |
9-26-2018 Insider Buy |
James P. Tobin Director |
$73.37
CAGR »
|
$36,685.00 500 shares |
7-27-2017 Insider Buy |
James P. Tobin Director |
$64.64
CAGR »
|
$32,320.00 500 shares |
3-24-2016 Insider Buy |
Steven J. Quinlan VP & CFO |
$44.73
CAGR »
|
$100,007.34 2,236 shares |
1-28-2016 Insider Buy |
Jack C. Parnell Director |
$50.25
CAGR »
|
$653.25 13 shares |
9-22-2015 Insider Buy |
Steven J. Quinlan VP & CFO |
$47.17
CAGR »
|
$49,998.19 1,060 shares |
9-22-2015 Insider Buy |
Thomas H. Reed Director |
$47.80
CAGR »
|
$191,180.80 4,000 shares |
8-3-2015 Insider Buy |
Clayton K. Yeutter Director |
$58.32
CAGR »
|
$29,160.00 500 shares |
4-20-2015 Insider Buy |
Richard E. Calk Jr. President & COO |
$45.84
CAGR »
|
$248,674.40 5,425 shares |
7-24-2014 Insider Buy |
Steven J. Quinlan Vice President & CFO |
$42.96
CAGR »
|
$39,995.76 931 shares |
10-18-2012 Insider Buy |
A. Charles Fischer Director |
$42.49
CAGR »
|
$42,490.00 1,000 shares |
5-21-2012 Insider Buy |
Clayton K. Yeutter Director |
$39.00
CAGR »
|
$9,750.00 250 shares |
12-27-2011 Insider Buy |
Clayton K. Yeutter Director |
$30.92
CAGR »
|
$114,404.00 3,700 shares |
12-27-2011 Insider Buy |
Steven J. Quinlan Vice President & CFO |
$31.12
CAGR »
|
$100,005.36 3,214 shares |
12-23-2011 Insider Buy |
A. Charles Fischer Director |
$30.91
CAGR »
|
$30,910.00 1,000 shares |
10-11-2011 Insider Buy |
Clayton K. Yeutter Director |
$34.87
CAGR »
|
$5,056.15 145 shares |
8-23-2011 Insider Buy |
William T. Boehm Director |
$35.06
CAGR »
|
$17,530.00 500 shares |
8-15-2011 Insider Buy |
Clayton K. Yeutter Director |
$36.47
CAGR »
|
$36,465.00 1,000 shares |
8-4-2011 Insider Buy |
Richard T. Crowder Director |
$38.11
CAGR »
|
$19,055.00 500 shares |
8-4-2011 Insider Buy |
Steven J. Quinlan Vice President & CFO |
$37.19
CAGR »
|
$18,595.00 500 shares |
Also See: Institutional Holders of NEOG
Also See: SEC filings
Below we present the annualized performance delivered by Neogen stock since 4-17-2024 (the date of the most recent
insider purchase). The performance of the investment from the time Neogen insider buying occurred is the ultimate
test of whether insiders were right about NEOG being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/18/2024 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$11.93 |
|
End price/share: |
$11.96 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
0.25% |
|
Annualized Gain: |
13.11% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$10,025.00 |
|
Years: |
0.02 |
|
Neogen Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent Neogen insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding NEOG
|
|